Related references
Note: Only part of the references are listed.The CCR2 3′UTR functions as a competing endogenous RNA to inhibit breast cancer metastasis
Jinhang Hu et al.
JOURNAL OF CELL SCIENCE (2017)
The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity
Pratima Basak et al.
BMC CANCER (2015)
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Giovanni Ciriello et al.
CELL (2015)
RhoGTPases - A novel link between cytoskeleton organization and cisplatin resistance
Daphna Mokady et al.
DRUG RESISTANCE UPDATES (2015)
RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer
Erin M. Griner et al.
MOLECULAR CANCER RESEARCH (2015)
StarD13 is a tumor suppressor in breast cancer that regulates cell motility and invasion
Samer Hanna et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis
Raul Aguirre-Gamboa et al.
PLOS ONE (2013)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
MicroRNA-125b Induces Metastasis by Targeting STARD13 in MCF-7 and MDA-MB-231 Breast Cancer Cells
Feng Tang et al.
PLOS ONE (2012)
An Improved Flp Deleter Mouse in C57Bl/6 Based on Flpo Recombinase
Andrea Kranz et al.
GENESIS (2010)
DLC2 modulates angiogenic responses in vascular endothelial cells by regulating cell attachment and migration
Y. Lin et al.
ONCOGENE (2010)
Deleted in Liver Cancer 2 (DLC2) Was Dispensable for Development and Its Deficiency Did Not Aggravate Hepatocarcinogenesis
Tai On Yau et al.
PLOS ONE (2009)
Deleted in Liver Cancer 1 Controls Cell Migration through a Dial-Dependent Signaling Pathway
Gerlinde Holeiter et al.
CANCER RESEARCH (2008)
ShcA signalling is essential for tumour progression in mouse models of human breast cancer
Josie Ursini-Siegel et al.
EMBO JOURNAL (2008)
StARD13(Dlc-2) RhoGap mediates ceramide activation of phosphatidylglycerolphosphate synthase and drug response in Chinese hamster ovary cells
Grant M. Hatch et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
DLC-1: a Rho GTPase-activating protein and tumour suppressor
Marian E. Durkin et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)
Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity
THY Leung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis
A Hakem et al.
GENES & DEVELOPMENT (2005)
Chromosome 13q12 encoded Rho GTPase activating protein suppresses growth of breast carcinoma cells, and yeast two-hybrid screen shows its interaction with several proteins
GM Nagaraja et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures
J Debnath et al.
METHODS (2003)
Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma
YP Ching et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Metastasis suppressors alter the signal transduction of cancer cells
PS Steeg
NATURE REVIEWS CANCER (2003)
Compilation of published comparative genomic hybridization studies
S Struski et al.
CANCER GENETICS AND CYTOGENETICS (2002)
Share Paper
